JAG1 and tuberculosis: Although the first critical step in developing an improved TB vaccine requires the discovery and selection of vaccine target Ags with proven immunogenicity and protective efficacy in preclinical animal testing, only a few early-stage Ags, such as Ag85A, Ag85B, and ESAT-6, are considered promising Ags for prophylactic vaccines17, 34, 35.